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Biological activities of phthalocyanines XIV. Effect of hydrophobic
phthalimidomethyl groups on the in vivo phototoxicity and mechanism of
photodynamic action of sulphonated aluminium phthalocyanines
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Summary Aluminium phthalocyanines substituted to different degrees with hydrophilic sulphonic acid and
hydrophobic phthalimidomethyl groups were investigated in vivo as new agents for the photodynamic therapy
of malignant tumours. Parameters studied included the photodynamic action on EMT-6 mammary tumours in
BALB/c mice, the therapeutic window and the potential for direct cell killing, assayed via an in vivo/in vitro
test. Although the efficiency of photoinactivation of the EMT-6 tumour increases by a factor of ten with
reduction of the number of sulphonic acid groups from four to two, no further effect was seen with the
addition of the hydrophobic phthalimidomethyl groups. Addition of the latter groups however increased the
potential for direct cell killing by a factor of two and expanded the therapeutic window by a factor of four,
thus improving the usefulness of the dye as a photosensitiser for the photodynamic therapy of cancer.
Photodynamic therapy of cancer is a treatment which
exploits the ability of certain dyes to absorb light and, via an
excited state, interact with and cause damage to substrate
molecules. If the dye, through differential rates of uptake or
release by neoplastic tissue, as compared to normal tissue,
concentrates in the tumour, activation with light of appropri-
ate wavelengths can induce selective destruction of the malig-
nant tumour (Kessel, 1984; Moan, 1986; Dougherty, 1987).
Porphyrin based photosensitisers and in particular Photofrin
IItm (P-IT), a commercially available preparation of
haematoporphyrin derivatives, have been extensively inves-
tigated; however, although these compounds absorb visible
light efficiently at short wavelengths (E4NZ 105M- cm 1),
they have much less intense absorbance maxima at useful
therapeutic wavelengths (6630103M-' cm '). Phthalocya-
nines (Pc) have been proposed as sensitisers to supersede P-II
(for reviews see van Lier & Spikes, 1989; van Lier, 1990;
Rosenthal, 1991). This is due to the high molar absorptivity
of these compounds at wavelengths permitting greater penet-
ration of light in normal tissues (typically e 105M-cm-I
at 670-680 nm when fully monomerised). Due to the extreme
insolubility of unsubstituted Pc in most common solvents,
attention has focused mainly on sulphonated derivatives,
which are water soluble.
A correlation has been found to exist between hyd-
rophobicity of the sulphonated Pc and photodynamic
potency (Brasseur et al., 1978a), the activity increasing as the
number of sulphonic acid groups is decreased from four to
two. It has been postulated (Paquette et al., 1988) that this
relationship is due to the increasing amphiphilic nature of the
lower sulphonates, which leads to greater membrane penetra-
tion. We recently tested this hypothesis, in vitro, using
sulphonated phthalimidomethyl aluminium phthalocyanine
(AlPcSP) (Figure 1), a novel photosensitiser substituted with
both hydrophilic and hydrophobic groups (Paquette et al.,
1991a). It was found that the lower sulphonated fractions,
with added phthalimidomethyl groups, were more effective
with regard to photodynamic inactivation of V-79 Chinese
hamster fibroblasts, compared to the corresponding sul-
phonates without phthalimidomethyl substituents. This en-
hanced photoactivity was directly related to cell uptake of
these dyes and correlated to an increase in the hydrophobic
character due to the addition of the phthalimidomethyl
groups.
We now present in vivo photodynamic tumour response
results, and evaluate the potential for direct tumour cell
killing for these substituted sulphonated phthalocyanines. In
addition, it has been reported that PDT can result in vascular
stasis and traumatic shock reactions (Ferrario & Gomer,
1990), mediated by release of eicosanoids from endothelial
cells (Fingar et al., 1991), and histamine from degranulation
of mast cells (Lim et al., 1986; Kerdel, 1987). Thus, to
establish the therapeutic window of these drugs, we have
investigated the drug dose at which inflammatory response
following PDT becomes deleterious, or fatal.
Materials and methods
Photosensitisers
The synthesis and purification of sulphonated aluminium
phthalocyanine (AlPcS) and sulphonated phthalimidomethyl
aluminium phthalocyanine (AlPcSP) have been described in
detail previously (Ali et al., 1988; Paquette et al., 1991a).
Briefly: AlPcSP was synthesised in a 'one pot' reaction which
introduced both sulpho and phthalimidomethyl groups on to
the AlPc molecule in one step. The crude reaction product
was a mixture of AlPcs substituted to different degrees with
sulpho and phthalimidomethyl groups which was subse-
quently purified by reverse phase chromatography. Eluted
fractions were analysed to determine the degree of substitu-
tion which was then assigned e.g. AlPcS2.4P1.4 was substituted
to an average level of 2.4 sulphonic acid groups and 1.4
phthalimidomethyl groups. Retention times (R,) for reverse
phase HPLC, which reflect polarity of the compounds, were
AlPcS3.2PO.4, Rt = 28-33 min; AlPcS2.4P12, Rt=40 min. Pho-
tofrin IIt' (P-IT) was obtained from Quadralogic Tech-
nologies Inc., Vancouver, B.C. Spectral characteristics
include: AlPcS, 8MOH = 1.9 X IO M1 cm ', Am. = 674 nm;
AlPcSP, SMOH = 1.5 x 105M'1 cm , Ilmax = 676 nm; P-II,
6HZ0; 103 M- cm1', ma = 623 nm.
Photodynamic therapy
Animal experiments were conducted following the recom-
mendations of the Canadian Council on Animal Care and of
an in-house ethics committee. The animals were allowed free
access to water and food throughout the experiments. Male
BALB/c mice had one tumour transplanted into the right
hind thigh by intradermal injection of 2 x 105 EMT-6 mam-
mary cells suspended in 0.05 ml of Waymouths' medium
(Gibco). Mice were injected intravenously, via the tail vein,
with Pc or P-IT in a solution of Cremophor EL (Sigma),
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Figure 1 Chemical structure of sulphonated phthalimidomethyl
aluminium phthalocyanine (AlPcSP). R = H, S03- or CH2-
phthalimide, depending on the degree of substitution and sul-
phonation.
propane-1,2-diol, and saline (10:3:87) 6-9 days post-
inoculation when tumours had reached a diameter of
3-5 mm. After 24 h the tumour was irradiated with
650-700 nm light (400 J cm-2 at a fluence rate of
180 mW cm-2) delivered by a 1000 W Xenon lamp fitted with
10 cm water filter, and LS-700 (Corion) and 2-58 (Corning)
filters. In the case of P-II a band of 600-650 nm was used at
the same fluence, and fluence rate, using LS-600 (Corion) and
650-FL07-50 (Ealing) filters. Light was focused on the
tumour with lenses to give a final beam 8 mm in diameter.
Tumour temperature was measured (Brasseur et al., 1987b)
and rose to 35°C (externally) and 32°C (internally) after
10 min, in both cases the temperature remained constant for
the remainder of the irradiation time. Tumour response was
assessed qualitatively and followed from initial necrosis
(within 48 h), to cure (within 15-30 days). Cure was defined
as complete eradication of tumour mass and regrowth of
non-neoplastic tissue in its place. Nine mice were used to
confirm the minimal dose of dye needed to reach the cure.
Results
The potential of photosensitisers to affect tumours upon
PDT via a direct cell killing mechanisms can be deduced
using an in vivo/in vitro cell survival assay (Henderson, 1990).
Photosensitisers were injected intravenously at a dose of
10ftmol kg-' or 10 mg kg-' for P-II in BALB/c mouse bear-
ing an EMT-6 tumour on the hind thigh. 24 h later neoplas-
mic cells were isolated, plated in dishes, and illuminated at a
dose ranging from 1 to 40 J cm-2. The cell survival curves
for two differently substituted fractions, AlPcS3.2PO.4 and
AlPcS2.4PI.2, relative to standards AlPcS2 and P-1I, are shown
in Figure 2. This assay confirmed the poor direct cell killing
potential of P-IT as only about 20% EMT-6 cells were
photoinactivated at the maximum fluence of 40 J cm-2. On
the other hand, the intrinsic character of sulphonated frac-
tions ofphthalocyanine to provide direct cell killing increased
with addition ofphthalimidomethyl groups. LD90 values app-
roximately half of that observed with AlPcS2 (15.7 J cm-2)
were obtained with AlPcS2.4P,.2 and AlPcS3.2P04 (5.2 and 6.4
Jcm-2).
The potential of these dyes to cure the EMT-6 tumour
implanted on BALB/c mice has also been tested. At a fluence
of 400 J cm-2, tumour response results for AlPcS3.2Po.4,
AlPcS2.4P,.2 and AlPcS2 indicate that all three compounds
gave an initial necrosis within 48 h, followed by a 100%
tumour cure, at similar injected doses (0.5timolkg-') with-
out apparent discomfort, and gave partial response at lower
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In vivo/in vitro assay
BALB/c mice were implanted with two EMT-6 tumours in
the hind thighs. When the tumours reached a diameter of
3-5 mm (6-9 days) mice were injected with 10 gsmol kg-' of
Pc or 10 mg kg-' of P-II in saline containing 10% Cremo-
phor EL and 3% propane-1,2-diol. 24 h post-injection of
drug animals were sacrificed and the tumours were excised,
minced, and enzymatically digested for 30 min in 10 ml Han-
k's buffer saline solution, containing 10 mM CaC12, 6.5 U
proteinase K (Sigma), 3 U nuclease micrococcal (Sigma) and
17 U collagenase (Sigma). The digested preparation was then
filtered through a 200 mesh sieve and centrifuged at 600 g for
5 min. Two hundred cells were placed in 60 mm Petri dishes
and incubated for 3 h at 37°C in 5% CO2 in Waymouths'
culture medium to allow adhesion to the support. Cells were
illuminated with red light from two 500 W tungsten/halogen
lamps (Sylvania) fitted with a circulating, refrigerated filter
containing aqueous Rhodamine (OD580 = 1.25), and a red
filter (Kodak, no. 23A). Cells were illuminated with a fluence
from 1 to 40 J cm-2calculated for a window of 40 nm centred
on the maximum absorption wavelength of each dye.
Therapeutic window
Tumour bearing animals were prepared and irradiated in a
procedure identical to that used for photodynamic therapy
(see above); however, in this experiment drug doses were
increased sequentially, until the lethal dose for PDT with that
compound was found. Any sub-lethal deleterious effects were
also assessed qualitatively.
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Figure 2 In vivo/in vitro survival curves of EMT-6 cells. 24 h
after injection of dye (phthalocyanine, 10tImol kg-'; Photofrin
II, 10 mg kg-'), EMT-6 cells were isolated from tumour bearing
BALB/c mice, placed in Petri dishes, and illuminated at a fluence
from 1 to 40 J cm-2. (@) Photofrin II, (V) AlPcS2 and (0)
AlPcS3.2PO4 (b) or AlPcS2.4PL2 (a). Experiments were repeated
three times using three dishes per points.
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doses. AlPcS4 and P-II attained the same tumour response
only at concentrations about 10 and 20 times higher, in
mgkg-' unit, respectively. Tumour response results for all
compounds tested are summarised in Table I.
The therapeutic window of these dyes was determined by
increasing progressively the injected dose. Results in Table II
indicate that AlPcS2 and AlPcS3.2P0.4 can be used safely in
this model under our experimental conditions, up to a limit
of 1 tmol kg-'. Above this dose, deleterious effect ranging
from inflammation to complete necrosis of the leg and death
result. Thus, these two dyes showed a poor therapeutic win-
dow as EMT-6 tumour could not be cured at a dose lower
than 0.5 jmol kg-1. On the other hand, increasing the
number of phthalimidomethyl groups, as in fraction
AlPcS24PI.4, increased the therapeutic window by a factor of
four as compared to AlPcS2.
Discussion
The use of Photofrin II'm in PDT protocols induces necrosis
mainly by tumour microcirculation stasis (Fingar & Hender-
son, 1987; Selman et al., 1985; Reed et al., 1989). The
resulting indirect cell killing is usually incomplete allowing
tumour regrowth unless blood vessels surrounding the
tumour are also destroyed (Star et al., 1986). In the clinic this
limits efficient treatment not only of single, well-defined
tumours where red light could be easily focused, but also
when more diffuse illumination must be used, as in the case
of multiple tumours in bladder cancer (Jocham et al.,1989).
Furthermore, severe damage to normal tissue could arise and
this deleterious effect greatly compromises successful cure of
malignant tumour. Accordingly there is a need for a new
PDT photosensitiser acting more directly on neoplasmic cells
and sulphonated phthalocyanines have shown promise in this
regard.
Apart from distribution and PDT effect in normal rat
colon with AlPcS purified with respect to sulfonation (Chat-
lani et al., 1991), most in vivo studies with sulphonated
aluminium phthalocyanines reported to date were conducted
with mixtures of differently sulphonated products (Barr et al.,
1990; Chan et al., 1986; Tralau et al., 1987). Resolution of
sulphonated metallo phthalocyanines into homogeneous com-
ponents requires tedious chromatographic procedures (Ali et
al., 1988) and mainly in vitro biological testing on these
individual compounds has been reported (Brasseur et al.,
Table I Photodynamic activity on EMT-6 tumour
Minimum dose requiredfor 100%
Sensitiser tumour curea
AlPcS2 0.5iLmol kg-' (0.38 mgkg-')
AlPcS4 5.0 tLmolkg-' (4.8 mgkg-')
AlPcS3.2Po.4 0.5jsmol kg-' (0.47 mg kg-')
AIPCS2.4P1.2 0.5lsmolkg'-l (0.5 mgkg-')
Photofrin IIF1 10 mgkg-'
a 24 hafterinjectionofphotosensitiser, tumourbearingBALB/cmice
wereilluminated at afluence of400J cm-2. Aninitial necrosisappeared
within 48 h post-treatment and was followed to cure.
1987a; Paquette et al., 1988; Peng et al., 1991). Although such
procedures allow for the comparison of the phototoxicity of
dyes after cell uptake, the procedure does not take into
account the many important in vivo parameters which govern
dye distribution and phototoxicity, including interactions
with blood components (albumin or lipoproteins), capillary
permeability in tumour, or distribution in interstitial tumour
space (for a recent review see Paquette and van Lier, 1991b).
Using the in vivo/in vitro cell survival assay as described in
this report, actual in vivo distribution and cell uptake of dye
are respected, while an in vitro illumination allows accurate
quantification of direct cell killing potential. EMT-6 cell
survival curves (Figure 2) after in vivo administration of
10 mg kg-' P-II revealed that at the maximum fluence of 40
J cm-2 only 20% of the EMT-6 cells were inactivated. How-
ever to elicit a complete in vivo tumour response with the
same dye dose, a 10-fold higher fluence of 400 J cm-2 was
required, suggesting that at least at the top layer of the
tumour, direct cell killing may contribute to tumour necrosis.
Overall tumour cell survival after in vivo PDT with P-IT has
previously been shown to be high, this suggests a
predominantly indirect action mechanism (Fingar & Hender-
son, 1987) which is in agreement with the high cell survival
observed in our in vivo/in vitro test.
Unlike P-II, all three phthalocyanines tested in this study
exhibited high potential for direct cell killing in PDT. In vitro
photoinactivation of EMT-6 cells after in vivo administration
of 10tcmol kg-' dye gave LD90 varying from 15.7 Jcm2 for
AlPcS2 through 5.2 and 6.4 J cm-2 for AlPcS2.4P,.2 and
AlPcS3.2P0.4 respectively (Figure 2). The phthalimidomethyl-
ated ALPcSP LD90 values are approximatley half that of
AlPcS2 which parallels their relative photoactivities under in
vitro conditions with Chinese hamster fibroblast V-79 cells
(Paquette et al., 1991a). In additon to passive diffusion, dye
uptake by neoplastic cells in vivo can be mediated by
endocytosis (Ben-Hur et al., 1987; Roberts and Berns, 1989).
These processes are modulated by dye interaction with cons-
tituents in interstitial liquid such as albumin, collagene or
low density lipoproteins, which compete with dye uptake by
neoplastic cells. On the other hand, binding of hydrophilic
dye on low density lipoprotein is believed to favour specific
endocytosis by neoplastic cells (Kessel et al., 1987). Our data
suggest that addition of phthalimidomethyl groups to AlPcS
favours their localisation in neoplasmic cells, resulting in a
two fold increase in direct cell killing and a 4-fold increase in
the therapeutic window.
Comparison of the in vivo and in vitro phototoxicities
(Paquette et al., 1991a) of the AlPcS and AlPcSP suggest that
the hydrophobic/amphiphilic properties of the dyes have less
impact on the in vivo as compared to the in vitro activities. In
the V-79 cell survival assay, the more hydrophobic and
amphiphilic AlPcS2.4PI.4 fraction was over 3-fold more
photoactive than the hydrophylic AlPCS3.2Po.4 fraction. In the
in vivo/in vitro EMT-6 cell survival assay, both dye prepara-
tions exhibited similar direct cell killing potentials. This sug-
gests the futility of further attempts to increase the
hydrophobic/amphiphilic character of these photosensitisers
in order to improve their direct cell killing potential during in
vivo PDT.
The degree of sulfonation of AlPcS strongly effects the
Table II Therapeutic window
Doseb in Jlmolkg-'
Sensitiser" 0.5 1.0 2.5 5.0 10
AlPcS2 Min. cure Cure + slight Lethal dose
dose oedema
AlPcS3.2Po.4 Min. cure Cure + slight Cure + para- Lethal dose
dose oedema lysis of leg
AIPCS2.4P].2 Min. cure Cure Cure Cure + slight Lethal
dose oedema dose
a Experiments with Photofrin II gave a lethal dose of 20mg kg-'. b 24 h after injection of
photosensitiser, tumourbearing BALB/cmicewereilluminated at afluence of400J cm2. An initial
necrosis appeared within 48 h post-treatment and was followed to cure.816 R.W. BOYLE et al.
minimal drug dose required for tumour response. Thus,
AIPcS2 is ten times more photoactive than the corresponding
AlPcS4 (0.5pmol kg-' and 5fmol kg-1, respectively),
confirming that the increase in hydrophobic/amphiphilic
character of AlPcS improves the effective overall distribution
of the dye in the tumour. This assumption is in agreement
with recent observations by Peng et al. (1990a,b) showing
that AlPcS2 at 24h post-injection, mainly localises in the
neoplastic cells of LOX tumour bearing mice. In contrast, the
AlPcS4 remained mainly in the stroma, even at 48 h post-
injection. It is likely that the highly hydrophilic character of
AlPcS4 contributes to strong binding to the protein compo-
nent in the stroma, while the amphiphilic nature of AlPcS2
promotes interaction with the plasma membrane of neoplas-
tic cells. Adding lipophilic phthalimidomethyl substituents to
AlPcS did not significantly improve the required dye dose for
100% tumour cure. Both AlPcS2.4P1.4 and AlPcS3.2P0.4 frac-
tions required, in our EMT-6 model, the same minimal dye
dose for tumour cure as AlPcS2 (0.5 Jmol kg-'). It thus
appears that the inclusion of hydrophobic phthalimidomethyl
groups in AlPcS has a beneficial PDT effect in that it
outweighs the expected decrease in activity resulting from
higher sulphonation levels (Brasseur et al., 1987a).
Extrapolation of the high direct cell killing potential of the
AlPcSP to the mechanisms of the PDT response of the
EMT-6 tumour, should be done with caution. Although the
minimal injected dye dose for tumour response was 20-fold
lower than the dye dose employed in the in vivo/in vitro cell
survival assay (0.5 and 10 tLmol kg-', respectively), the
fluence in the in vivo PDT assay was at least 60-fold higher
than that required for a 90% cell inactivation in the in vivo/in
vitro assay. Furthermore, absorption of red light by the
tumour tissue allows for only about 20% of incident light to
reach the lower part of tumour (Henderson, 1989). These
factors combined suggest that the deeper seated part of the
EMT-6 tumour will receive somewhat lower combined light/
dye doses than the LD90 values obtained in the in vivo/in vitro
cell killing assay. Thus it is likely that in the deeper seated
parts of the tumour, and at the lower effective dye doses,
tumour cure will involve indirect mechanism for cell killing.
Indirect tumour cell killing after PDT has been related to
the release ofvasoactive agents including histamine and pros-
taglandins, and this, in addition to local effects, could trigger
also substantial systemic toxicity (Fingar et al., 1991; Kerdel
et al., 1987; Lim et al., 1986). Accordingly, we evaluated the
therapeutic window in our tumour model, i.e. the range of
the minimal dye doses required for 100% tumour cure and
the dose which induced systemic toxicity (Table II). Under
our experimental conditions both AlPcS2 and AlPcS3.2PO.4
proved highly phototoxic at 5.0LLmol kg-' suggeting that,
although these compounds have a good potential for direct
cell killing, they also localise in sites responsible for the
release of inflammatory agents. Among the three sensitisers
which exhibit photodynamic action at 0.5 ltml kg-', the
AlPcS2.4PI.2 has the largest therapeutic window. This suggests
that the addition of the phthalimidomethyl group on
amphiphilic AlPcS2 reduces unwanted dye interaction with
cells capable of releasing vasoactive agents (e.g. mast cells).
In conclusion, these results imply a subtle balance between
the hydrophobic and the amphiphilic characteristics of
phthalocyanine sensitisers and their action mechanisms, with
important implications in terms of both photodynamic
potency and deleterious effects. The addition of the hyd-
rophobic phthalimidomethyl groups on lower sulphonated
AlPcS should improve the PDT outcome by increasing direct
tumour cell killing while limiting deleterious effects on nor-
mal surrounding tissue. In the EMT-6 tumour model, the
current class of phthalocyanines induces a higher direct cell
killing and tumour response as compared to P-1I. Further
chemical modifications should be aimed at improving the
therapeutic window, which would allow the administration of
higher doses of dye and red light, resulting in augmented
direct cell killing and cure of malignant tumours.
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